Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Purwin

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Pigment Cell & Melanoma Research|May 21, 2026
Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant MelanomaHaley P Wilson, Casey D Stefanski, Signe Caksa, et al.
Oncogene|January 20, 2022
Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanomaAnna Han, Vivian Chua, Usman Baqai, et al.
Cell Death & Disease|March 27, 2019
CADM1 is a TWIST1-regulated suppressor of invasion and survivalEdward J Hartsough, Michele B Weiss, Shea A Heilman, et al.
Molecular Cancer Therapeutics|November 15, 2017
Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas <i>In Vivo</i> and <i>Ex Vivo</i>Edward J Hartsough, Curtis H Kugel, Michael J Vido, et al.
Molecular Cancer Therapeutics|May 21, 2020
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal MelanomaJessica L F Teh, Timothy J Purwin, Anna Han, et al.
Cancer Discovery|December 5, 2019
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via PyroptosisDan A Erkes, Weijia Cai, Ileine M Sanchez, et al.
EMBO Molecular Medicine|January 6, 2019
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanomaVivian Chua, Marlana Orloff, Jessica Lf Teh, et al.
Cancer Immunology Research|November 26, 2025
Pyroptosis modulates multiple immune cell populations in targeted therapy-treated melanomaNicole A Wilski-Cronin, Dan A Erkes, Timothy J Purwin, et al.
Molecular Cancer Research : MCR|October 17, 2023
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell DeathSheera R Rosenbaum, Signe Caksa, Casey D Stefanski, et al.
Cell Reports|January 16, 2020
FOXD3 Regulates VISTA Expression in MelanomaSheera R Rosenbaum, Meghan Knecht, Mehri Mollaee, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Pigment Cell & Melanoma Research|May 21, 2026
Diacylglycerol Kinase Eta as a Novel Target in NRAS Mutant MelanomaHaley P Wilson, Casey D Stefanski, Signe Caksa, et al.
Oncogene|January 20, 2022
Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanomaAnna Han, Vivian Chua, Usman Baqai, et al.
Cell Death & Disease|March 27, 2019
CADM1 is a TWIST1-regulated suppressor of invasion and survivalEdward J Hartsough, Michele B Weiss, Shea A Heilman, et al.
Molecular Cancer Therapeutics|November 15, 2017
Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas <i>In Vivo</i> and <i>Ex Vivo</i>Edward J Hartsough, Curtis H Kugel, Michael J Vido, et al.
Molecular Cancer Therapeutics|May 21, 2020
Metabolic Adaptations to MEK and CDK4/6 Cotargeting in Uveal MelanomaJessica L F Teh, Timothy J Purwin, Anna Han, et al.
Cancer Discovery|December 5, 2019
Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via PyroptosisDan A Erkes, Weijia Cai, Ileine M Sanchez, et al.
EMBO Molecular Medicine|January 6, 2019
Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanomaVivian Chua, Marlana Orloff, Jessica Lf Teh, et al.
Cancer Immunology Research|November 26, 2025
Pyroptosis modulates multiple immune cell populations in targeted therapy-treated melanomaNicole A Wilski-Cronin, Dan A Erkes, Timothy J Purwin, et al.
Molecular Cancer Research : MCR|October 17, 2023
SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell DeathSheera R Rosenbaum, Signe Caksa, Casey D Stefanski, et al.
Cell Reports|January 16, 2020
FOXD3 Regulates VISTA Expression in MelanomaSheera R Rosenbaum, Meghan Knecht, Mehri Mollaee, et al.
Pageof 5